Krop Julie — SEC Form 4 filings
SEC reporting owner CIK 1643127. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-24.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-06-21 to 2026-06-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 25,000 shares, $125,392 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 25,000 shares @ $5.02 ($125,392) in Aquestive Therapeutics, Inc., filed 2026-06-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | Director | 4 | — | 1 leg · 25,000 sh · $125,392 | 5 |
| DiaMedica Therapeutics Inc. (DMAC) | Chief Medical Officer | 2 | — | — | 2 |
Form 4 filings — Krop Julie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-24 | 4 | Aquestive Therapeutics, Inc. (AQST) | Option exercise (M): 25,000 @ $0.71 · Sale (S): 25,000 @ $5.02 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 50,500 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | DiaMedica Therapeutics Inc. (DMAC) | Grant/award (A): 67,500 (derivative) @ $0 | EDGAR |
| 2025-11-03 | 4 | DiaMedica Therapeutics Inc. (DMAC) | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 42,000 (derivative) @ $3.41 | EDGAR |
| 2024-06-21 | 4 | Aquestive Therapeutics, Inc. (AQST) | Grant/award (A): 38,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1643127 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →